✦ LIBER ✦

Comparison of daunorubicin and daunorubicin-DNA complex in the treatment of acute nonlymphoblastic leukemia

✍ Scribed by Christer Paul; Magnus Björkholm; Inga Christenson; Lars Engstedt; Gösta Gahrton; Robert Hast; Göran Holm; Andreas Iillander; Bo Lantz; Dieter Lockner; Berit Lönnqvist; Håkan Mellstedt; Jan Palmblad; Curt Peterson; Bengt Simonsson; Ann-Marie Stalfelt; Ann-Mari Udén; Bengt Wadman; Gunnar Öberg

Book ID: 112285906
Publisher: Springer
Year: 1981
Tongue: English
Weight: 802 KB
Volume: 6
Category: Article
ISSN: 0344-5704
DOI: 10.1007/bf00253012

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Daunorubicin-DNA complex in acute nonlym

Daunorubicin-DNA complex in acute nonlymphoblastic leukemia

✍ R. Hulhoven; C. Harvengt; Christer Paul; Curt Peterson; Gösta Gaahrton; Andreas 📂 Article 📅 1982 🏛 Springer 🌐 English ⚖ 114 KB

Treatment of acute nonlymphoblastic leuk

Treatment of acute nonlymphoblastic leukemia in adults with daunorubicin-DNA complex: A preliminary report

✍ G. Gahrton; M. Björkholm; G. Brenning; I. Christenson; L. Engstedt; S. Franzén; 📂 Article 📅 1979 🏛 Springer 🌐 English ⚖ 314 KB

Comparison of the intracellular pharmaco

Comparison of the intracellular pharmacokinetics of daunorubicin and idarubicin in patients with acute leukemia

✍ Ulf Tidefelt; Britt Sundman-Engberg; Christer Paul 📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 428 KB

Liquid chromatographic monitoring of dau

Liquid chromatographic monitoring of daunorubicin and daunorubicinol in plasma from leukemic patients treated with daunorubicin or the daunorubicin-DNA complex

✍ B. Andersson; I. Andersson; M. Beran; H. Ehrsson; S. Eksborg 📂 Article 📅 1979 🏛 Springer 🌐 English ⚖ 249 KB

DAUNORUBICIN IN THE TREATMENT OF ACUTE M

DAUNORUBICIN IN THE TREATMENT OF ACUTE MYELOCYTIC LEUKÆMIA

✍ Boiron, M.; Jacquillat, C.; Weil, M.; Tanzer, J.; Levy, D.; Sultan, C.; Bernard, 📂 Article 📅 1969 🏛 The Lancet 🌐 English ⚖ 653 KB

Kinetics and sensitivity of daunorubicin

Kinetics and sensitivity of daunorubicin in patients with acute leukemia

✍ Michael W. DeGregorio; Walter M. Holleran; Bruce A. Macher; Charles A. Linker; J 📂 Article 📅 1984 🏛 Springer 🌐 English ⚖ 512 KB

Leukemia cells isolated from eight patients with acute leukemia before treatment were examined for in vitro uptake of daunorubicin (DNR) and inhibition of DNA synthesis. In addition, plasma and cellular levels of DNR and daunorubicinol (DOL) were examined in six of the eight patients. Inhibition of